Cargando…

Dystrophic epidermolysis bullosa: a review

Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility...

Descripción completa

Detalles Bibliográficos
Autor principal: Shinkuma, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451851/
https://www.ncbi.nlm.nih.gov/pubmed/26064063
http://dx.doi.org/10.2147/CCID.S54681
_version_ 1782374206702354432
author Shinkuma, Satoru
author_facet Shinkuma, Satoru
author_sort Shinkuma, Satoru
collection PubMed
description Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility and disease complications such as intractable ulcers, extensive scarring, malnutrition, and malignancy. The disease is usually diagnosed by immunofluorescence mapping and/or transmission electron microscopy and subsequently subclassified into one of 14 subtypes. This review provides practical knowledge on the disease, including new therapeutic strategies.
format Online
Article
Text
id pubmed-4451851
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44518512015-06-10 Dystrophic epidermolysis bullosa: a review Shinkuma, Satoru Clin Cosmet Investig Dermatol Review Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type VII collagen leads to subepidermal blistering immediately below the lamina densa, resulting in mucocutaneous fragility and disease complications such as intractable ulcers, extensive scarring, malnutrition, and malignancy. The disease is usually diagnosed by immunofluorescence mapping and/or transmission electron microscopy and subsequently subclassified into one of 14 subtypes. This review provides practical knowledge on the disease, including new therapeutic strategies. Dove Medical Press 2015-05-26 /pmc/articles/PMC4451851/ /pubmed/26064063 http://dx.doi.org/10.2147/CCID.S54681 Text en © 2015 Shinkuma. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Shinkuma, Satoru
Dystrophic epidermolysis bullosa: a review
title Dystrophic epidermolysis bullosa: a review
title_full Dystrophic epidermolysis bullosa: a review
title_fullStr Dystrophic epidermolysis bullosa: a review
title_full_unstemmed Dystrophic epidermolysis bullosa: a review
title_short Dystrophic epidermolysis bullosa: a review
title_sort dystrophic epidermolysis bullosa: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451851/
https://www.ncbi.nlm.nih.gov/pubmed/26064063
http://dx.doi.org/10.2147/CCID.S54681
work_keys_str_mv AT shinkumasatoru dystrophicepidermolysisbullosaareview